[Treatment possibilities of arterial circulatory disorders using calcitonin].
74 patients with arterial circulatory disorders have been treated with calcitonin in low dosages (0.25-0.5 mg s.c. or i.m. twice to three times weekly). In 3 women with Raynaud phenomenon in sclerodermia, previously refractory necroses of the finger-tips were cured. One woman with Raynaud disease became symptomfree. Marked improvements in the results of ergometric tests were observed in 8 out of 22 patients with intermittent claudication of the lower extremities. In 12 out of 31 patients with refractory angina pectoris, the attacks were practically eliminated. Remission of headaches of vascular origin was obtained in 6 out of 17 cases. Attacks of migraine were terminated in the incipient stage by treatment with 0.25 mg Cibacalcin.
D000368:Aged; D000787:Angina Pectoris / Q000188:drug therapy; D001157:Arterial Occlusive Diseases / Q000188:drug therapy*; D002116:Calcitonin / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007383:Intermittent Claudication / Q000188:drug therapy; D008297:Male; D008881:Migraine Disorders / Q000188:drug therapy; D009540:Nicotinyl Alcohol / Q000627:therapeutic use; D011928:Raynaud Disease / Q000188:drug therapy; D014653:Vascular Headaches / Q000188:drug therapy
D002116:Calcitonin; D009540:Nicotinyl Alcohol
Zur Behandlungsmöglichkeit der arteriellen Durchblutungsstörungen mit Calcitonin.